Geriatric Communication Skills Training Program for Oncology Clinicians
Not Applicable
Completed
- Conditions
- LymphomaBone Marrow TransplantGU CancerGI Cancer
- Interventions
- Behavioral: The Consultation and Relational Empathy (CARE) questionnaireBehavioral: Self-Efficacy AssessmentBehavioral: Consumer Assessment of Health Care Providers and Systems Program (CAHPS)Behavioral: UCLA Geriatrics Attitudes ScaleBehavioral: Course EvaluationsBehavioral: Patient activation measure (PAM) scale
- Registration Number
- NCT03530969
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to learn more about the effects of a training program designed to help doctors communicate better with older patients and their caregivers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Clinician Eligibility
- MSK medical oncology Health Care Professionals (HCP) - specifically identified as Attendings, fellows, or Advance Practice Professional (APP) - either a Nurse Practitioner (NP) or Physician Assistant (PA) from GI, GU Oncology, Lymphoma, Bone Marrow Transplant or Geriatrics Service (five services with a large number of geriatric patients)
- Willingness to be audio-recorded as per self-report
- Clinician has individual clinic consultations with patients in the target population: 65 years of age and over, English speaking, and patients who have had a new visit within the last 6 months.
Patient Eligibility
- MSK patients 65 years of age and over as per EMR
- English speaking as per EMR
- Being seen by one of the consented HCPs as per the HCP and/or electronic medical record (EMR)
- Willingness to be audio-recorded as per self-report
- Patient had their first visit with the clinician within the last 6 months
Caregiver Eligibility
- English speaking as per EMR
- Accompanying an MSK patient being seen by one of the consented HCPs as per the HCP and/or EMR
Read More
Exclusion Criteria
- N/A
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Participants with GI/GU/Lymphoma Cancer The Consultation and Relational Empathy (CARE) questionnaire Patients of the physicians in group 1 Participants with GI/GU/Lymphoma Cancer Consumer Assessment of Health Care Providers and Systems Program (CAHPS) Patients of the physicians in group 1 GI/GU/Lymphoma Oncologists Self-Efficacy Assessment Doctors specializing in treating gastrointestinal cancer (cancer of the stomach, pancreas, colon, etc.), genitourinary cancer (cancer of the genitals and urinary tract), and lymphoma (cancer affecting the blood and lymph nodes) GI/GU/Lymphoma Oncologists Course Evaluations Doctors specializing in treating gastrointestinal cancer (cancer of the stomach, pancreas, colon, etc.), genitourinary cancer (cancer of the genitals and urinary tract), and lymphoma (cancer affecting the blood and lymph nodes) Participants with GI/GU/Lymphoma Cancer Patient activation measure (PAM) scale Patients of the physicians in group 1 GI/GU/Lymphoma Oncologists UCLA Geriatrics Attitudes Scale Doctors specializing in treating gastrointestinal cancer (cancer of the stomach, pancreas, colon, etc.), genitourinary cancer (cancer of the genitals and urinary tract), and lymphoma (cancer affecting the blood and lymph nodes) Caregivers of Participants with GI/GU/Lymphoma Cancer Consumer Assessment of Health Care Providers and Systems Program (CAHPS) Family members or caregivers of the patients in group 2 Caregivers of Participants with GI/GU/Lymphoma Cancer The Consultation and Relational Empathy (CARE) questionnaire Family members or caregivers of the patients in group 2
- Primary Outcome Measures
Name Time Method Feasibility of Health Care Provider (HCP) training 8 weeks Measured by number of HCP successfully recruited for the training
Participants satisfaction with Health Care Provider (HCP) training 1 week Self-reported measure of satisfaction
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States